Indian equities witnessed sharp swings before ending lower amid expiry-day volatility and rising geopolitical concerns. Profit booking in b...

Indian equities lost momentum after a positive start, with Nifty closing lower and broader markets declining sharply. Investor caution ahea...

Domestic equities ended lower amid global uncertainty and caution ahead of key US inflation data. Despite market weakness, analysts remain ...

ICICI Securities maintains a Buy call on Akums Drugs & Pharmaceuticals, setting a target price of Rs 710. The company reported a consolidat...

ICICI Securities has given a buy call for Akums Drugs & Pharmaceuticals with a target price of Rs 710, citing profitable growth potential. ...

Akums Drugs and Pharmaceutical, a Delhi-based company, reported a 16% rise in profits compared to the same period last year. The company ac...

Akum Drugs Share Price: Akum Drugs and Pharmaceuticals' shares dropped 5% to Rs 895 despite reporting a Rs 60 crore net profit for the June...

Akums Drugs and Pharmaceuticals saw its shares rise 8% to Rs 784.6 on its debut, despite a strong subscription rate of 63.44 times. Analyst...

Akums Drugs and Pharmaceuticals' shares began trading at Rs 725, a 6.8% premium over the issue price of Rs 679, after an IPO that was subsc...

Akums Drugs and Pharmaceuticals will debut on Tuesday. The stock, with a GMP of Rs 140, is expected to list at a 21% premium over the upper...

Akums Drugs & Pharma share allotment has been finalised. Shares will be out on August 6. The IPO was subscribed 63.5 times. Proceeds will a...

Non-institutional investors subscribed 22.8 times, followed by retail investors, whose category was booked 13.8 times. The part reserved fo...

In the unlisted market, shares of the company are currently commanding a premium of 26% over the IPO price, with GMP of Rs 175. The IPO its...

Akums Drugs IPO Review GMP, Subs: Akums Drugs and Pharmaceuticals' IPO, valued at Rs 1,857 crore, closed on August 1. The issue included Rs...

Akums Drugs &Pharma, a prominent contract development and manufacturing company in India, launched an ₹1,856-crore IPO with ₹680 crore in f...

Akums Drugs and Pharma's IPO, open from July 30 to August 1, targets raising Rs 1857 crore. The company specializes in pharmaceutical devel...

Looming expiry of tax incentives, rising raw material costs and a fluctuating rupee add to pharma contract manufacturers' woes.